 |
BioWorld-International-2004-12-08
PhotoCure Shares Slide As FDA Says No To Metvix PDT
PhotoCure Shares Slide As FDA Says No To Metvix PDT
PhotoCure ASA's efforts to obtain U.S. approval for its Metvix photodynamic therapy as a treatment for basal-cell carcinoma hit another roadblock last week, as FDA officials ruled that the clinical data submitted in its new drug application were insufficient for approval. (BioWorld International)